The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes: An Interim Analysis of the TRIDENT Study

Affiliations

¹ Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
² Division of Nephrology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
³ Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
⁴ Division of Nephrology, Oregon Health & Science University, Portland, Oregon.
⁵ Division of Nephrology, University of Texas Health at San Antonio, San Antonio, Texas.
⁶ Division of Nephrology and Hypertension, Department of Medicine, University of Miami Leonard Miller School of Medicine, Miami, Florida.
⁷ Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
⁸ Division of Nephrology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
⁹ Division of Nephrology, Baylor University Medical Center, Dallas, Texas.
¹⁰ Division of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
¹¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹² Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹³ University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Observational Study

Jonathan J Hogan et al. Clin J Am Soc Nephrol. 2020.

. 2020 Jul 1;15(7):1024-1026.

doi: 10.2215/CJN.13061019. Epub 2020 Apr 27.

¹ Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
² Division of Nephrology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.
³ Division of Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio.
⁴ Division of Nephrology, Oregon Health & Science University, Portland, Oregon.
⁵ Division of Nephrology, University of Texas Health at San Antonio, San Antonio, Texas.
⁶ Division of Nephrology and Hypertension, Department of Medicine, University of Miami Leonard Miller School of Medicine, Miami, Florida.
⁷ Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
⁸ Division of Nephrology, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York.
⁹ Division of Nephrology, Baylor University Medical Center, Dallas, Texas.
¹⁰ Division of Nephrology and Hypertension, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
¹¹ Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹² Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
¹³ University of North Carolina Kidney Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

No abstract available

Keywords: Biopsy; Feasibility Studies; diabetes mellitus; diabetic nephropathy; kidney biopsy.

References

1. Townsend RR, Guarnieri P, Argyropoulos C, Blady S, Mottl AK, Ross MJ, Sarov-Blat L, Boustany-Kari C, Palmer M, Patel U, Morton L, Devalaraja-Narashimha K, Steinbugler K, Susztak K; TRIDENT Study Investigators: Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) study [published correction appears in Kidney Int 97: 809, 2020]. Kidney Int 97: 10–13, 2020
1. Corapi KM, Chen JL, Balk EM, Gordon CE: Bleeding complications of native kidney biopsy: A systematic review and meta-analysis. Am J Kidney Dis 60: 62–73, 2012 - PubMed
1. Korbet SM, Gashti CN, Evans JK, Whittier WL: Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury. Clin Kidney J 11: 610–615, 2018 - PMC - PubMed
1. Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B: Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clin Kidney J 10: 573–577, 2017 - PMC - PubMed
1. Moledina DG, Luciano RL, Kukova L, Chan L, Saha A, Nadkarni G, Alfano S, Wilson FP, Perazella MA, Parikh CR: Kidney biopsy-related complications in hospitalized patients with acute kidney disease. Clin J Am Soc Nephrol 13: 1633–1640, 2018 - PMC - PubMed